Human HIV-1 gp120 protein (Recombinant) (STJP000355)
SPECIFICATIONS
ConjugationUnconjugated
General Information
| Short Description | Recombinant-Human HIV-1 gp120-protein was developed from. For use in research applications. |
| Note | STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Formulation | 0.2 Β΅m filtered 50mM Tris pH 8.0 NaCl 60mM, 10mM Glutathione, 0.25% Sarkosyl, 50% Glycerol |
| Storage Instruction | Can be stored in working aliquots atΒ°C-Β°C C for one month, or at-20Β°C C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. NA |
| Endotoxin | Endotoxin content was assayed using a LAL gel clot method. Endotoxin level was found to be less than.1 ng/Β΅g (1EU/Β΅g). NA |
| Immunoreactivity | Immunoreative with sera of infected HIV individuals NA |
Target Information
Additional Info
| Background | Recombinant HIV-1 Glycoprotein gp120 contains a GST purification tag and migrates as an approximately 35 kDa protein under reducing conditions in SDS-PAGE. |
Information sourced from Uniprot.org